Ray-Coquard I - Search Results

1

Long term survival in adult osteosarcoma patients treated with a two-drug regimen: Final results of the OSAD93 phase II study of the FSG-GETO.

Blay JY, Penel N, Toulmonde M, Valentin T, Chaigneau L, Rios M, Saada-Bouzid E, Firmin N, Bertucci F, Marec-Berard P, Ray-Coquard I, Lervat C, Rolland F, Thyss A, Conroy T, Brahmi M, Dufresne A, Merrouche Y, Brunat-Mentigny M, Biron P, Bompas E, Perol D; French Sarcoma Group. Blay JY, et al. Eur J Cancer. 2024 Sep;208:114228. doi: 10.1016/j.ejca.2024.114228. Epub 2024 Jul 15. Eur J Cancer. 2024. PMID: 39018632 Free article. Clinical Trial.

2

[Targeted treatment of cancers with imatinib mesylate (STI571, Gleevec): results of Asco 2002].

Ray-Coquard I, Blay JY. Ray-Coquard I, et al. Bull Cancer. 2002 Jun;89(6):567-9. Bull Cancer. 2002. PMID: 12135855 Free article. French. No abstract available.

3

[Gastro-intestinal stromal tumors: news and comments].

Ray-Coquard I, Le Cesne A, Michallet V, Boukovinas I, Ranchere D, Thiesse P, Baty V, Blay JY. Ray-Coquard I, et al. Bull Cancer. 2003 Jan;90(1):69-76. Bull Cancer. 2003. PMID: 12609807 Free article. Review. French.

4

[Anemia and chemotherapy].

Ray-Coquard I, Bachelot T, Sebban C, Biron P, Guastalla JP, Blay JY. Ray-Coquard I, et al. Bull Cancer. 2003 Apr;90 Spec No:S133-43. Bull Cancer. 2003. PMID: 12856425 Free article. Review. French.

5

Risk model predictive of severe anemia requiring RBC transfusion after chemotherapy in pediatric solid tumor patients.

Marec-Berard P, Blay JY, Schell M, Buclon M, Demaret C, Ray-Coquard I. Marec-Berard P, et al. J Clin Oncol. 2003 Nov 15;21(22):4235-8. doi: 10.1200/JCO.2003.09.121. J Clin Oncol. 2003. PMID: 14615453

6

Targeting other abnormal signaling pathways in sarcoma: EGFR in synovial sarcomas, PPAR-gamma in liposarcomas.

Blay JY, Ray-Coquard I, Alberti L, Ranchère D. Blay JY, et al. Cancer Treat Res. 2004;120:151-67. doi: 10.1007/1-4020-7856-0_9. Cancer Treat Res. 2004. PMID: 15217223 Review. No abstract available.

7

CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer.

Borg C, Ray-Coquard I, Philip I, Clapisson G, Bendriss-Vermare N, Menetrier-Caux C, Sebban C, Biron P, Blay JY. Borg C, et al. Cancer. 2004 Dec 1;101(11):2675-80. doi: 10.1002/cncr.20688. Cancer. 2004. PMID: 15503313 Free article.

8

[Organization and impact of the multidisciplinary committee in oncology].

Castel P, Blay JY, Meeus P, Sunyach MP, Ranchère-Vince D, Thiesse P, Bergeron C, Marec-Bérard P, Lurkin A, Ray-Coquard I. Castel P, et al. Bull Cancer. 2004 Oct;91(10):799-804. Bull Cancer. 2004. PMID: 15556881 Free article. French.

9

[Cancer: epidemiology, carcinogenesis, tumor evolution, classification].

Blay JY, Ray-Coquard I. Blay JY, et al. Rev Prat. 2004 Nov 15;54(17):1935-42. Rev Prat. 2004. PMID: 15655920 Review. French. No abstract available.

10

Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma.

Claude L, Perol D, Ray-Coquard I, Petit T, Blay JY, Carrie C, Bachelot T. Claude L, et al. Radiother Oncol. 2005 Sep;76(3):334-9. doi: 10.1016/j.radonc.2005.06.004. Epub 2005 Jul 15. Radiother Oncol. 2005. PMID: 16024123 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

628 results

Search Page

Filters